New

Middle East & Africa Diltiazem Market

2021

Middle East & Africa Diltiazem Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Capsules, Injection, and Tablets) and Application (Angina, Hypertension, and Others)

Publication Month: Oct 2021 | Report Code: TIPRE00025365 | No. of Pages: 124 | Category: Pharmaceuticals | Status: Published

Market Insights

Middle East & Africa Diltiazem Market to Grow at a CAGR of 10.9% to reach US$ 38.55 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Middle East & Africa diltiazem market is expected to reach US$ 38.55 million by 2028 from US$ 18.68 million in 2021; it is estimated to grow at a CAGR of 10.9% from 2021 to 2028.


Rise in government initiatives for promotion, increase in the prevalence of cardiovascular diseases (CVDs), and rise in the elderly population with heart diseases worldwide are expected to boost the market growth over the years. However, the side effects of Diltiazem on consumption are likely to impact the market's growth in the coming years negatively.

Heart diseases are primarily observed in older adults due to their weak immunity and other major health problems. According to the Global Ageing 2019 survey, the world's population of 65 and above totaled 703 million in 2019. The elderly demographic is expected to double to 1.5 billion people by 2050. This demographic is more susceptible to CVDs such as arrhythmias. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. Structural and functional changes in the cardiovascular system associated with aging are major causes of cardiovascular diseases. Therefore, the rising geriatric population worldwide is leading to an increase in the incidence of cardiovascular disease, bolstering the growth of the diltiazem market. Also, the diltiazem market is characterized by the presence of various small and big companies. The market players adopt new product launches, regional expansions, and product approvals to increase their market share. The players are investing in R&D to develop advanced technologies and gain significant revenue share in the Middle East. For instance, in March 2021, Glenmark Pharmaceuticals was granted competitive generic therapy (CGT) designation for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg; therefore, it is eligible for 180 days of CGT exclusivity upon commercial marketing. Thus, such recent developments are expected to act as a future trend in the diltiazem market

The COVID-19 outbreak has shown substantial effects in the Middle East & Africa. The region has observed an increasing number of patients admitted to intensive care units (ICUs). A rising number of medications impose multiple diagnostic and therapeutic challenges on stressed healthcare systems, leading to a rise in medical devices and pharmaceuticals. Also, the number of cases with chronic conditions has increased, resulting in increased use of drugs to combat the virus. During the widespread COVID-19 pandemic, there have been worries about the potential of certain blood pressure medications such as angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-converting blockers (ARB). The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptors to facilitate entry into the host cell. Hence, this pandemic has enhanced the business operation of the various drug manufacturers operating in the diltiazem market in the region with relatively low impact.

Get more information on this report :


MIDDLE EAST AND AFRICA DILTIAZEM MARKET SEGMENTATION

By Product Type

  • Tablet
  • Capsules
  • Injection

By Application

  • Hypertension
  • Angina
  • Others

By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Company Profiles

  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd
  • MYLAN N.V.
  • Pfizer Inc.
  • Sandoz (Novartis AG)
  • Sun Pharmaceutical Industries Ltd
  • Hikma Pharmaceuticals PLC
  • Zydus Cadila
  • Glenmark

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East and Africa Diltiazem Market – By Product Type

1.3.2 Middle East and Africa Diltiazem Market – By Application

1.3.3 Middle East and Africa Diltiazem Market – By Country

2. Middle East and Africa Diltiazem Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Diltiazem Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Middle East and Africa – PEST Analysis

4.3 Experts Opinion

5. Diltiazem Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Cardiovascular Disease Incidence

5.1.2 Increasing Elderly Population

5.2 Market Restraints

5.2.1 Side Effects of Diltiazem

5.3 Market Opportunities

5.3.1 Growth Opportunities in Developing Nations

5.4 Future Trends

5.4.1 Recent Developments in Market

5.5 Impact Analysis

6. Diltiazem Market –Middle East and Africa Analysis

6.1 Middle East and Africa Diltiazem Market Revenue Forecast and Analysis

7. Diltiazem Market Analysis and Forecasts to 2028 – Product Type

7.1 Overview

7.2 Diltiazem Market Share by Product Type 2021 & 2028 (%)

7.3 Capsules

7.3.1 Overview

7.3.2 Capsules Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Injection

7.4.1 Overview

7.4.2 Injection Market Revenue and Forecast to 2028 (US$ Mn)

7.5 Tablets

7.5.1 Overview

7.5.2 Tablet Market Revenue and Forecast to 2028 (US$ Mn)

8. Diltiazem Market Analysis And Forecasts TO 2028 – Application

8.1 Overview

8.2 Diltiazem Market Share by Application 2021 & 2028 (%)

8.3 Angina

8.3.1 Overview

8.3.2 Angina Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Hypertension

8.4.1 Overview

8.4.2 Hypertension Market Revenue and Forecast to 2028 (US$ Mn)

8.5 Others

8.5.1 Overview

8.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

9. Diltiazem Market – Middle East and Africa Analysis

9.1 Middle East and Africa: Diltiazem Market

9.1.1 Overview

9.1.2 Middle East & Africa: Diltiazem Market - Revenue and Forecast to 2028 (US$ Million)

9.1.3 Middle East and Africa Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.4 Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.5 Middle East and Africa: Diltiazem Market, by Country, 2021 & 2028 (%)

9.1.5.1 Saudi Arabia: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1 Saudi Arabia: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.2 Saudi Arabia Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.5.1.3 Saudi Arabia Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.5.2 UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1 UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.2 UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3 UAE Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.5.2.4 UAE Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.5.3 South Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1 South Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.2 South Africa Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.5.3.3 South Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.5.4 Rest of Middle East and Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.4.1 Rest of Middle East and Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.4.2 Rest of Middle East and Africa Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.5.4.3 Rest of Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Diltiazem Market

10.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11. Diltiazem Market–Industry Landscape

11.1 Overview

11.2 Recent Growth Strategies In The Diltiazem Market

12. Company Profiles

12.1 Bausch Health Companies Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Teva Pharmaceutical Industries Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 MYLAN N.V.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Pfizer Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Sandoz (Novartis AG)

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Sun Pharmaceutical Industries Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Hikma Pharmaceuticals PLC

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Zydus Cadila

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Glenmark

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Athenex

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms


LIST OF TABLES

Table 1. Middle East and Africa Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 2. Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 5. UAE Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 6. UAE Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7. South Africa Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 8. South Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 9. Rest of Middle East and Africa Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Rest of Middle East and Africa Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. Glossary of Terms, Diltiazem Market


LIST OF FIGURES

Figure 1. Diltiazem Market Segmentation

Figure 2. Diltiazem Market Segmentation, By Country

Figure 3. Middle East and Africa Diltiazem Market Overview

Figure 4. Tablets Held the Largest Share of the Product Segment in Diltiazem Market

Figure 5. Middle East and Africa Diltiazem Market – Leading Country Markets (US$ Million)

Figure 6. Middle East and Africa PEST Analysis

Figure 7. Diltiazem Market: Impact Analysis of Drivers and Restraints

Figure 8. Middle East and Africa Diltiazem Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. Diltiazem Market Share by Product Type 2021 & 2028 (%)

Figure 10. Capsules Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Injection Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Tablet Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Diltiazem Market Share by Application 2021 & 2028 (%)

Figure 14. Angina Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Hypertension Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Middle East and Africa: Diltiazem Market, by Key Country – Revenue (2021) (USD Million)

Figure 18. Middle East & Africa Diltiazem Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. Middle East and Africa: Diltiazem Market, by Country, 2021 & 2028 (%)

Figure 20. Saudi Arabia: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. UAE: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. South Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Rest of Middle East and Africa: Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets

  1. Bausch Health Companies Inc.
  2. Teva Pharmaceutical Industries Ltd
  3. MYLAN N.V.
  4. Pfizer Inc.
  5. Sandoz (Novartis AG)
  6. Sun Pharmaceutical Industries Ltd
  7. Hikma Pharmaceuticals PLC
  8. Zydus Cadila
  9. Glenmark
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa diltiazem market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa diltiazem market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00025365
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.